Protective effect of Panax notoginseng saponins on acute myocardial ischemia in rats

Shu-yan HAN,Xu MA,Hai-xia LI,Ke ZHANG,Peng-fei TU
DOI: https://doi.org/10.3867/j.issn.1000-3002.2012.04.006
2012-01-01
Abstract:OBJECTIVE: To explore the effect of Panax notoginseng saponins (PNS) pretreatment on acute myocardial ischemia in rats. METHODS: The rats were ig given PNS 0, 25, 50, 100, 200, 400, 600 and 800 mg·kg-1, twice a day, for 7 times. After the last administration for 30 min, the acute myocardial ischemia model was induced by left anterior descending coronary artery ligation. The percentage of the myocardial infarct size was determined by TTC staining after 24 h, and left ventricular carotid artery blood flow dynamics was monitored by a biological signal acquisition and analysis system. Meanwhile, the cardiac enzymes related to myocardial infarction were assayed by an automatic biochemical analyzer. RESULTS: Compared with model group, PNS 50, 100, 200 and 400 mg·kg-1 pretreatment significantly reduced infarct size in myocardial ischemia rats, decreased left ventricular end-diastolic pressure, improved left ventricular systolic pressure, and increased the maximum rate of increase/decrease in left ventricular pressure. Serum levels of lactate dehydrogenase and creatine kinase were significantly lowered; α- hydroxybutyrate dehydrogenase and aspartate aminotransferase were also obviously decreased. CONCLUSION: PNS 50 - 400 mg·kg -1 could significantly reduce myocardial infarct size, improve left ventricular diastolic and systolic function and inhibit the release of myocardial enzymes.
What problem does this paper attempt to address?